Medicure (MCUJF) Projected to Post Quarterly Earnings on Tuesday

Medicure (OTCMKTS:MCUJF) is anticipated to issue its results after the market closes on Tuesday, May 19th. Analysts expect the company to announce earnings of ($0.0439) per share and revenue of $3.6260 million for the quarter.

Medicure (OTCMKTS:MCUJF) last announced its quarterly earnings data on Thursday, April 23rd. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.04) by ($0.25). The firm had revenue of $6.13 million during the quarter, compared to analyst estimates of $3.62 million. Medicure had a negative net margin of 24.61% and a negative return on equity of 41.55%.

Medicure Stock Performance

Shares of Medicure stock opened at $0.75 on Tuesday. Medicure has a fifty-two week low of $0.60 and a fifty-two week high of $0.97. The firm has a market cap of $7.83 million, a price-to-earnings ratio of -1.53 and a beta of 0.97. The company has a quick ratio of 0.77, a current ratio of 1.02 and a debt-to-equity ratio of 0.03. The business has a fifty day simple moving average of $0.83 and a 200-day simple moving average of $0.84.

Medicure Company Profile

Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical‐care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.

Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.